Assuming developed is required, the following 46 results were found.
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Insurance
-
prevents both smallpox and the related disease monkeypox in adults. Marketed under the brand name JYNNEOS, the vaccine was developed by biotechnology firm Bavarian Nordic and tested by the U.S. Army Medical Research Institute of Infectious Diseases...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
MG-Neshemhttps://virustreatmentcenters.com/virus/generic-antiviral-medications/mg-neshem
vs with cisplatin every 4 weeks. Patients receiving larger doses of cisplatin (80-100 mg/m2 compared with 50-60 mg/m2) developed hypomagnesemia more quickly. Although hypomagnesemia is usually mild, the concentration of Mg in the serum can fall to...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Generic Antiviral Medications
-
safety and efficacy of the company’s investigational, non-replicating smallpox vaccine, IMVAMUNE®. The product is being developed as an alternative to the current U.S. licensed replicating smallpox vaccine, ACAM2000®, which cannot be used by certain...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
pathogens. Army scientists at the at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) have developed the first lethal mouse model of SARS-CoV-2, the virus that causes COVID-19. The model utilizes mice that were genetically...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
independent biosecurity experts that the COVID-19 pandemic may have arisen from a lab accident in China. USAMRIID has not developed a COVID-19 vaccine candidate, though the lab has tested COVID-19 vaccines in the pre-clinical trial stage, according to...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
technologies to discover new targets and validate their worth. Fred Hutch cancer chemical biologist Behnam Nabet, PhD, has developed a method that uses targeted protein degradation to pinpoint key cancer-causing proteins. This will allow the team to...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
APIS+ Sterile Plasmahttps://virustreatmentcenters.com/medical-supplies/apis-plasma
by Virus Treatment Center’s scientists and engineers. The process of turning beeswax into viable fresh frozen plasma was developed at USMRICD by USMC CMC Correo Hofstad and USMC CMC Melody Bouck. Avis TC is currently available by trial at Fred...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Medical Supplies for Hospitals, Clinics, and Laboratories
-
NiMaxhttps://virustreatmentcenters.com/helminths/generic-helminth-medication/nimax
long-term use of anti-parasitic drugs has led to the emergence of drug resistance and adverse side effects. VirusTC has developed plant-derived compounds as an alternative approach to controlling parasitic infections. These agents do not target only the...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Generic Anti-Helminth Medications
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
Plant-based hemoglobins are recombined with AVIS+ Sterile Plasma in a process developed at Harborview Medical Center by USMC CMC Correo Hofstad and USMC CMC Melody Bouck. VirusTC products provide high-alkalinity solutions. Our formulas are highly...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Medical Supplies for Hospitals, Clinics, and Laboratories
-
Soldier uses a piece of technology for protection, intelligence, shooting, movement or to communicate, chances are it was developed, tested and fielded by an APG organization. The APG Virtual Career Fair event page on Facebook includes information on...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
(LLNL), collaborating with researchers at the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD), have developed a new, versatile antidote to counteract exposure to nerve agent poisoning. The compound, called “LLNL-02” was found to...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
Access Non-GMO, antigen-free, generic antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated generic antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, Mayo Clinic, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.